IQVIA™ Real-World Insights Bibliography

GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Author(s): Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations(s): IQVIA, Eli Lilly
Publication(s):  Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Type(s): Article,
Countries: Belgium, Canada, France, Germany, Italy, Netherlands ,
Click here for the abstract
C:
Y:
Diabetes,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
A population-based analysis of anti-diabetic medications in four Canadian provinces: secular trends and prescribing patterns
Author(s): Secrest MH, Azoulay L, Dahl M, Clemens KK, Durand M, Hu N, Targownik L, Turin TC, Dormuth CR, and Filion KB
Affiliations(s): IQVIA, Cambridge, MA
Publication(s):  Pharmacoepidemiology & Drug Safety (in press)
Document Type(s): Article, In press/to be published,
Countries: Canada,
C:
Y:
Diabetes, Drug Utlization Study,
2019
  L:
A:
English
Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
The Pharmacoepidemiology of Anti-Depressant Prescribing Trends in Canadian Children from 2012 to 2016
Author(s): Aysha Lukmanji1BA&Sc, Tamara Pringsheim2,3MD, Andrew G. Bulloch1,3PhD, David G Stewart1, Parco Chan1, Ali Tehrani1, Scott B. Patten1,3,4MD PhD
Affiliations(s): 1Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW Calgary, Alberta T2N 4Z6, Canada 2 Department of Clinical Neurosciences 3 Mathison Center for Research & Education, Hotchkiss Brain Institute, University of Calgary 4Cuthbertson & Fischer Chair in Pediatric Mental Health, University of Calgary. 5 IQVIA Canada
Publication(s):  J Child Adolesc Psychopharmacol. 2019 Jul 29. doi: 10.1089/cap.2019.0018
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:

2019
  L:
A:
English
  Add to report
 
 
PRODUCTIVITY LOSS IN THE FIRST YEAR AFTER A CARDIOVASCULAR EVENT IN CANADA: A CROSS SECTIONAL STUDY OF WORKING ADULTS
Author(s): A. Shekhar Pandey, B.Sc., MD, FRCPC, ABIM, CBNC;1 Milan Gupta, MD, FRCPC, FACC;1 Theodore Wein, MD, FRCPC, FAHA;2 Aren Fischer, MSc;3 Johanna Mancini, BSc, MSc, PhD;3 Eduard Sidelnikov, MD, PhD;4 Raina Rogoza, MSc;5 Louisa Pericleous, MSc, PhD.5
Affiliations(s): 1Department of Medicine, McMaster University, Hamilton, ON, Canada; 2Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; 3IQVIA, Mississauga, ON, Canada; 4AMGEN, Europe GmbH, Rotkreuz, Switzerland; 5AMGEN; Mississauga, ON, Canada.
Publication(s): 
Document Type(s): Poster,
Countries: Canada,
C:
Y:
Cardiovascular disease,
2019
  L:
A:
English
  Add to report
 
 
Trends in Psychotropic Medication Use for Canadian Children and Youth with ASD from 2010 to 2016: A Pharmacoepidemiologic Study
Author(s): McMorris, C.A.1, Patten, S.2, Stewart, D.3, Tehrani, A.3 & Pringsheim, T.2
Affiliations(s): 1 Werklund School of Education, University of Calgary (Calgary, AB Canada) 2 Cumming School of Medicine, University of Calgary (Calgary, AB Canada)
Publication(s): 
Document Type(s): Poster,
Countries: Canada,
C:
Y:
Mental health,
2019
  L:
A:
English
Database Study,
  Add to report
 
 
Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A Pharmacoepidemiologic Study
Author(s): Nicholas Cothros1, Davide Martino1, Carly McMorris2,3, David Stewart4, Ali Tehrani4 & Tamara Pringsheim1,5,6*
Affiliations(s): 1Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Hotchkiss Brain Institute, Foothills Hospital, Calgary, AB, CA, 2Werklund School of Education, Alberta Children?s Hospital Research Institute (ACHRI), University of Calgary, Calgary, AB, CA, 3The Owerko Centre, Child Development Centre (CDC), Calgary, AB, CA, 4IQVIA, Kanata, ON, CA, 5Department of Psychiatry, Cumming School of Medicine, University of Calgary, Foothills Hospital, Calgary, AB, CA, 6Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB, CA
Publication(s):  Tremor Other Hyperkinet Mov (N Y)v.9; 2019
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Mental health,
2019
  L:
A:
English
Survey research,
  Add to report
 
 
LANDSCAPE TRANSFORMATION: pCPA CHANGES AND IMPACT TO MARKET ACCESS IN CANADA ? RESULTS FROM AN OBSERVATIONAL CROSS-SECTIONAL STUDY
Author(s): Minhas, Jagdeep, M.Biotech1; Iqbal-Khan, Sarah, MBA2; Laforty, Callahan, MSc2; Ling, Juejing, MSc2; Shi, Scott, PharmD2; Millson, Brad, MBS1
Affiliations(s): 1Health Access and Outcomes, IQVIA, 535 Legget Drive, Kanata, ON, K2K 3B8; 2Health Access and Outcomes, IQVIA, 6700 Century Avenue, Mississauga, ON, L5N 6A4
Publication(s):  CADTH Symposium 2019, Edmonton, AB, April 14-16, 2019
Document Type(s): Poster,
Countries: Canada,
C:
Y:

2019
  L:
A:
English
  Add to report
 
 
Anti-VEGF persistence and switching in nAMD: real world analysis from a Canadian claims database
Author(s): Tina Maio-Twofoot 1, Alexandros Sagkriotis 2, Atif Kukaswadia 3, Fran?ois Lebeau 1, Valerie Gregory 1
Affiliations(s): 1 Novartis Pharmaceuticals Canada Inc., 2 Novartis Pharma AG; 3 IQVIA
Publication(s): 
Document Type(s): Poster,
Countries: Canada,
C:
Y:
Ophthalmology,
2019
  L:
A:
English
Longitudinal study, Observational study, Retrospective database analysis,
  Add to report
 
 
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Author(s): Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1
Affiliations(s): 1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada.
Publication(s):  Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7.
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Obesity,
2019
  L:
A:
English
  Add to report
 
 
Reduction in the Utilization of Prednisone or Methotrexate in Canadian Claims Data Following Initiation of Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis
Author(s): Majed M M Khraishi1, Brad Millson2, John Woolcott3, Lisa Marshall4 and Heather Jones4
Affiliations(s): 1Memorial University of Newfoundland, St John's, NF, Canada, 2IQVIA, Kanata, ON, Canada, 3Global Outcomes & Evidence, Pfizer, Collegeville, PA, 4Pfizer, Collegeville, PA
Publication(s):  Annals of the Rheumatic Diseases 2018;77:494.
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Pediatrics, Rheumatology,
2019
  L:
A:
English
Longitudinal study, Retrospective database analysis,
  Add to report
 
 
 1 of 11 Next Page Last Page